Phathom Pharmaceuticals, Inc. PHAT Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $180.9M+39.2% | $129.97M-3.8% | $135.16M-9.6% | $149.57M-29.6% | $212.32M-28.6% | ||
| $2.86M0.0% | $2.86M0.0% | $2.86M0.0% | $2.86M0.0% | $2.86M0.0% | ||
| $80.72M+3.3% | $78.13M+40.0% | $55.79M+8.8% | $51.26M+40.9% | $36.36M-6.3% | ||
| $19.08M-8.0% | $20.73M-14.0% | $24.1M-2.3% | $24.68M+7.2% | $23.01M+99.4% | ||
| $8.44M-45.1% | $15.35M+16.1% | $13.23M-9.5% | $14.62M+12.0% | $13.06M-37.4% | ||
| $276.57M+20.8% | $228.97M+10.2% | $207.78M-5.1% | $218.88M-17.4% | $264.9M-26.4% | ||
| $1.02M-4.5% | $1.06M-8.0% | $1.16M-6.9% | $1.24M-8.3% | $1.35M-8.3% | ||
| $2.51M-3.6% | $2.6M-3.4% | $2.69M+209% | $873K+125% | $388K-36.7% | ||
| $3.09M+5.9% | $2.92M+72.3% | $1.69M0.0% | $1.69M0.0% | $1.69M0.0% | ||
| $305.12M+17.7% | $259.15M+7.8% | $240.29M-4.0% | $250.22M-15.0% | $294.21M-22.2% | ||
| $6.37M+27.7% | $4.98M+364% | $1.08M-73.2% | $4.01M-65.5% | $11.62M+10.6% | ||
| —— | $7.5M-88.5% | $65.35M+1.6% | $64.3M+49.4% | $43.03M-19.2% | ||
| $33.02M+21.2% | $27.25M+11.9% | $24.34M+13.1% | $21.53M+24.7% | $17.27M-12.7% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $667K+2.9% | $648K+9.6% | $591K+148% | $238K-24.7% | $316K-36.9% | ||
| $347.9M-0.6% | $350.12M+0.3% | $348.98M+0.6% | $347M+0.9% | $343.81M+3.2% | ||
| $1.68M-8.6% | $1.83M+3.9% | $1.76M+0.5% | $1.76M-2.7% | $1.8M+5.4% | ||
| $125.04M-5.3% | $132.04M+41.8% | $93.12M+1.4% | $91.82M+24.0% | $74.03M-13.6% | ||
| $163.68M-21.7% | $209.09M+1.0% | $207.09M+1.0% | $205.14M+0.9% | $203.25M+0.9% | ||
| $1.96M-5.0% | $2.07M-2.7% | $2.12M+260% | $589K— | —— | ||
| $2.63M-3.1% | $2.71M0.0% | $2.71M+228% | $827K+162% | $316K-36.9% | ||
| $3.5M-12.5% | $4M-65.2% | $11.5M0.0% | $11.5M0.0% | $11.5M0.0% | ||
| $642.08M-7.9% | $697.32M+5.2% | $662.82M+1.0% | $656.05M+3.7% | $632.58M+0.1% | ||
| $7K+16.7% | $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | ||
| $1.18B+12.6% | $1.05B+0.5% | $1.04B+1.3% | $1.03B+0.8% | $1.02B+0.9% | ||
| -$1.51B-2.0% | -$1.48B-1.4% | -$1.46B-2.1% | -$1.43B-5.6% | -$1.36B-7.5% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| -$336.96M+23.1% | -$438.17M-3.7% | -$422.53M-4.1% | -$405.83M-19.9% | -$338.38M-33.4% | ||
| $305.12M+17.7% | $259.15M+7.8% | $240.29M-4.0% | $250.22M-15.0% | $294.21M-22.2% | ||
| $3.09M+5.9% | $2.92M+72.3% | $1.69M0.0% | $1.69M0.0% | $1.69M0.0% | ||
| $2.51M-3.6% | $2.6M-3.4% | $2.69M+209% | $873K+125% | $388K-36.7% | ||
| $2.51M-3.6% | $2.6M-3.4% | $2.69M+209% | $873K+125% | $388K-36.7% | ||
| $3.09M+5.9% | $2.92M+72.3% | $1.69M0.0% | $1.69M0.0% | $1.69M0.0% | ||
| $2.51M-3.6% | $2.6M-3.4% | $2.69M+209% | $873K+125% | $388K-36.7% | ||
| $3.09M+5.9% | $2.92M+72.3% | $1.69M0.0% | $1.69M0.0% | $1.69M0.0% | ||
| $347.9M-0.6% | $350.12M+0.3% | $348.98M+0.6% | $347M+0.9% | $343.81M+3.2% | ||
| $83.32M-7.3% | $89.83M+37.5% | $65.35M+1.6% | $64.3M+49.4% | $43.03M-19.2% | ||
| $83.32M-7.3% | $89.83M+37.5% | $65.35M+1.6% | $64.3M+49.4% | $43.03M-19.2% | ||
| —— | $7.5M— | —— | —— | —— | ||
| $347.9M-0.6% | $350.12M+0.3% | $348.98M+0.6% | $347M+0.9% | $343.81M+3.2% | ||
| $347.9M-0.6% | $350.12M+0.3% | $348.98M+0.6% | $347M+0.9% | $343.81M+3.2% | ||
| $166.3M-21.5% | $211.8M+0.9% | $209.81M+1.9% | $205.97M+1.2% | $203.56M+0.8% | ||
| $1.18B+12.6% | $1.05B+0.5% | $1.04B+1.3% | $1.03B+0.8% | $1.02B+0.9% | ||
| $7K+16.7% | $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Phathom Pharmaceuticals, Inc.'s total assets?
- Phathom Pharmaceuticals, Inc. (PHAT) holds $305.1M in total assets, up 3.7% year over year.
- How much debt does Phathom Pharmaceuticals, Inc. have?
- Phathom Pharmaceuticals, Inc. carries $166.3M in total debt against -$337.0M of shareholders' equity, a debt-to-equity ratio of 5.64.
- How much cash does Phathom Pharmaceuticals, Inc. have?
- Phathom Pharmaceuticals, Inc. holds $180.9M in cash and equivalents.
- Can Phathom Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 2.21 — current assets exceed current liabilities.
- Where does Phathom Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Phathom Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
